Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$3.97 -0.03 (-0.75%)
At close: Nov 10, 2026 · 4:00 PM EST

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Dividends payables of $264,000 for Q2 2026, down 12.9% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Dividends payables (2025 - 2026) Analysis & Trends

At the end of FY2025, Oramed Pharmaceuticals posted Dividends payables of $10.6 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.13 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oramed Pharmaceuticals 164.02 Mn -170.72 Mn - 264,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 264,000.00
Mar 31, 2026 303,000.00
Dec 31, 2025 10.60 Mn
API Access

Oramed Pharmaceuticals Dividends payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-payables&ticker=ORMP&period=max&api_key=YOUR_API_KEY